As the bioanalytical market evolves at a rapid pace, KCAS Bio stands at the forefront, offering an innovative approach to challenges and opportunities alike. Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with…

Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…

Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…

KCAS Bio is excited to sponsor the upcoming Pharmaceutical & BioScience Society (PBSS) workshop “Antibody-Drug Conjugates from Discovery to Development: Chemistry, Engineering, Characterization, CMC, PK/Tox, Clinical Design and Intellectual Property,” on December 10th from 8:45am – 5:30pm PST in San Diego, California at the Hyatt Regency – La Jolla. Showcasing…

This infographic explores the key trends in flow cytometry, software and instrumentation based on results from a recent Spotlight survey. It highlights the top challenges for biomarker analysis using flow cytometry, including lack of standardized control materials, sourcing a suitable laboratory and uncertain regulatory expectation, as well as what the…

Please download this poster, “Validation of a 15-Color Spectral Flow Cytometry Panel for Globally Harmonized Comprehensive Leukocyte Profiling in Human Whole Blood: Translational and Clinical Applications “ CYTEK_ValidatedPanels_EBF2024_20241118Download…

Please download this poster, “Comparative Evaluation of Ligand Binding Assay Platforms for BiomarkerQuantification: Critical Considerations for Ensuring Data Quality and Project Success” LBAPlatforms_EBF2024_Poster_vfDownload…

KCAS Bio is excited to announce our participation in the Society of Toxicology (SOT) Annual Meeting and ToxExpo, taking place in Orlando, Florida on March 16th-20th. As one of the largest gatherings of toxicologists and life sciences professionals, this event offers a unique platform to connect with leaders in toxicology…

KCAS Bio is thrilled to announce our attendance at the upcoming J.P. Morgan Healthcare Conference, a premier gathering that draws top leaders, decision-makers, and innovators from across the life sciences and healthcare industries. As we join this influential event in San Francisco, KCAS Bio is eager to connect with industry…

KCAS Bio is excited to sponsor the upcoming Pharmaceutical & BioScience Society (PBSS) workshop, “Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapies,” in Foster City, California. Dawn Dufield, Ph.D., will be presenting “Bioanalysis for Biologics and Cell/Gene Therapy Products…

Webinar Description: KCAS Bio will present results from a recent validation of two IP panels on the Cytek Aurora in PBMCs. We have analyzed the impact of different fixation buffers on the efficacy of reference controls over time, and we will explore how to help improve workflow standards and process…

KCAS Bio has embarked on a global initiative to harmonize its spectral flow cytometry services across four labs in three countries, collaborating with Crux Biolabs and Cytek Biosciences. This effort ensures standardized flow cytometry services across sites in the U.S., Europe, and Australia. As trials increasingly span multiple regions, global…